SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 52 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $547,000 | +1.1% | 52,100 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $541,000 | -43.9% | 52,100 | -34.8% | 0.01% | -33.3% |
| Q3 2018 | $964,000 | -11.2% | 79,963 | -12.7% | 0.01% | -20.0% |
| Q2 2018 | $1,085,000 | -19.2% | 91,567 | +4.9% | 0.02% | -28.6% |
| Q1 2018 | $1,343,000 | -2.3% | 87,322 | -14.6% | 0.02% | +5.0% |
| Q4 2017 | $1,375,000 | -26.6% | 102,300 | -8.0% | 0.02% | -25.9% |
| Q3 2017 | $1,873,000 | +450.9% | 111,200 | +342.6% | 0.03% | +440.0% |
| Q2 2017 | $340,000 | – | 25,123 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 785,950 | $9,314,000 | 0.91% |
| Morse Asset Management, Inc | 177,500 | $2,103,000 | 0.58% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 281,213 | $3,332,000 | 0.38% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $860,000 | 0.33% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,883,000 | 0.31% |
| Private Capital Advisors, Inc. | 52,335 | $620,000 | 0.19% |
| SECTORAL ASSET MANAGEMENT INC | 131,656 | $1,560,000 | 0.17% |
| Lee Financial Co | 18,750 | $222,000 | 0.05% |
| Baker Brothers Advisors | 373,144 | $4,422,000 | 0.03% |
| Alyeska Investment Group, L.P. | 200,000 | $2,370,000 | 0.02% |